Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEHP.L Share News (EHP)

  • There is currently no data for EHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Neptune Calculus Income & Growth VCT Hit By Epistem Share Decline

Tue, 19th Nov 2013 15:56

LONDON (Alliance News) - Neptune-Calculus Income & Growth VCT PLC Tuesday said its net asset value per share declined by 4.9% during the third quarter, as a result of a decline in the share price of AIM-quoted Epistem Holdings PLC, one of the companies in which it invests.

"[Epistem] although still valued at 300% of original cost, saw a decline it its share price following the termination of a supply and distribution agreement with Becton Dickinson for its product "Genedrive"," Neptune said in a statement.

Neptune said it is still positive on Epistem's long-term prospects. Epistem shares were Tuesday quoted at 323.00, down 2.2% and not much above their 52-week low of 310.00 pence. The shares have traded as high as 585.00 pence in the period.

Neptune said the remainder of the quoted portfolio increased by 30% on a like-for-like basis compared with the FTSE All Share which increased by 4.7%

Neptune's net asset value per share was 52.69 pence on September 30, compared to 55.43 pence on June 30.

Shares in Neptune were Tuesday quoted at 40.00 pence, up 14%.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright © 2013 Alliance News Limited. All Rights Reserved.

More News
28 Oct 2014 08:27

Epistem Files For Import, Sales Licence For Genedrive In India

Read more
22 Jul 2014 09:23

Epistem Expects Full Year Loss, Signs Funding Agreement For Genedrive

Read more
7 Apr 2014 16:00

DIRECTOR DEALINGS: Epistem Holdings Managing Director Transfers Shares

LONDON (Alliance News) - Epistem Holdings PLC Monday said Managing Director Catherine Booth transferred 4,877 shares to her self invested personal pension fund at a price of 328 pence. Booth's interest remains unchanged at 985,642 shares following this transaction, representing a 10.11% sta

Read more
25 Mar 2014 13:12

Epistem Loss Widens As It Ups Investment, Revenue Declines

LONDON (Alliance News) - Epistem Holdings PLC Tuesday posted a widened pretax loss as it saw revenue decline in the half-year ended December 31, 2013, and it upped its investment in the development of its Genedrive product. Genedrive is a molecular diagnostic technology. Epistem poste

Read more
25 Mar 2014 06:12

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, March 25 
888 Holdi

Read more
24 Mar 2014 15:39

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, March 25 
888 Holdi

Read more
27 Jan 2014 10:15

EpiStem Appoints COO And Technical Director For Diagnostics Division

LONDON (Alliance News) - EpiStem Holdings PLC said Monday that it had appointed for its Diagnostics division Allan Brown as chief operating office and Peter Foster as technical director. Brown will take on the role February 1. He previously held positions at Tepnel Life Sciences PLC and QIA

Read more
3 Dec 2013 15:59

Hangar 8 CEO makes first sale to meet demand for stock

Hangar 8, a privately-owned passenger jet aircraft owner, announced that Dustin Dryden, its Chief Executive Office, made his first ever sale of company stock with the disposal of 750,000 shares to meet institutional demand. Dryden sold the shares at 205p each for a total of £1.54m and reduced his

Read more
22 Oct 2013 11:41

UPDATE: Epistem Widens Pretax Losses Following Delays Of Key Product, Looking To Launch In 2014

Read more
22 Oct 2013 08:05

Epistem Widens Pretax Losses Following Delays Of Key Product

Read more
7 Oct 2013 10:12

DIRECTOR DEALINGS: Epistem Chief Executive, Directors Acquire Shares

Read more
9 Sep 2013 11:37

UK Winners & Losers: BG Down 5%, CSR Up 5%; Mediazest Drops 21%

Read more
9 Sep 2013 11:34

Epistem Holdings Says Expansion Talks With US Becton Dickinson Failed

Read more
9 Sep 2013 08:00

EpiStem loses distribution contract for TB test

AIM-listed biotech firm EpiStem has maintained its full-year guidance for the period just gone but admitted that talks over a key supply and distribution agreement for its TB test have fallen through. The company was in discussions with medical technology company Becton Dickinson (BD) to expand the

Read more

Quickpicks are a member only feature

Login to your account